CIC::DUX4 Sarcoma With Preferentially Expressed Antigen in Melanoma (PRAME) Immunopositivity

John Grove1, Rana Naous2

  • 1Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.

Cureus
|July 2, 2025
PubMed
Summary

CIC::DUX4 sarcoma, a rare cancer, is difficult to diagnose and treat. This study reports strong PRAME staining in a CIC::DUX4 sarcoma case, suggesting a new diagnostic marker for this challenging disease.